Stephen Gadomski earned his B.S. from the University of Scranton, M.D. from the Medical University of South Carolina, and Ph.D. from the University of Cambridge as part of the Gates Cambridge and NIH Oxford-Cambridge Scholars Program.
Stephen has been studying components of the bone marrow niche since 2017, when he examined the role of different types of bone marrow endothelial cells in orchestrating hematopoiesis under the supervision of Dr. Jonathan Keller. In 2019, he began examining the neural niche and characterized the sympathetic cholinergic system in bone and marrow under the supervision of Prof. Simon Mendez-Ferrer. During this time, under the joint supervision of Dr. Pamela Robey and Prof. Andrew McCaskie, he assessed chondrogenic differentiation in human skeletal stem cells and induced pluripotent stem cells, and developed a cell therapy with potential use for osteoarthritis.
Stephen is a clinical pathology resident at Mass General Brigham with hopes to pursue clinical training in hematopathology and informatics alongside investigative work in bone marrow and other niches.